![Kathleen Clarence-Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Clarence-Smith
Fondateur chez
Km Pharmaceutical Consulting LLC
Profil
Kathleen E.
Clarence-Smith was the founder of Prestwick Scientific Capital, Inc. founded in 1996, OXIS Biotech, Inc. founded in 2014, Georgetown Translational Pharmaceuticals, Inc. founded in 2015, and Chase Pharmaceuticals Corp.
founded in 2007 where the title of Chief Medical Officer was held from 2014 to 2016.
Dr. Clarence-Smith is also the founder of Prestwick Chemical, Inc.,Prestwick Pharmaceuticals, Inc.,Km Pharmaceutical Consulting LLC..
Dr. Clarence-Smith currently holds the position of Director at Riverside Pharmaceuticals Corp., Westhaven Therapeutics Corp., and DAS Therapeutics, Inc. Dr. Clarence-Smith is a Member of the American Academy of Neurology since 1990.
Former positions include Vice Chairman & President-Neurology Division at GT Biopharma, Inc. from 2018 to 2018, Senior Director-CNS Clinical Development at Hoffmann-La Roche, Inc., Director at Chase Therapeutics Corp., Research Analyst at Stanford Group Co., and Head-CNS Group at Sanofi from 1987 to 1987.
Education includes a doctorate from Université François-Rabelais de Tours.
Postes actifs de Kathleen Clarence-Smith
| Sociétés | Poste | Début |
|---|---|---|
Km Pharmaceutical Consulting LLC
 Km Pharmaceutical Consulting LLC Km Pharmaceutical Consulting LLC is a specialized consulting and project management firm serving the pharmaceutical industry. The private company is based in Washington, DC. The company provides strategic consulting and regulatory services throughout drug development, including clinical and non-clinical program management, FDA regulatory interactions, and patent and licensing strategies. It supports clients with early strategic planning, oversight, and customized team assembly, particularly assisting non-US companies and biotech firms lacking US-based resources. The company’s expertise includes clinical trial design and management, regulatory submissions, development plan formulation, safety and efficacy data interpretation, and due diligence. The company was founded by Kathleen E. Clarence-Smith. | Fondateur | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | 01/01/1990 |
Riverside Pharmaceuticals Corp.
 Riverside Pharmaceuticals Corp. MiscellaneousMiscellaneous Operates as a non-classified establishment | Directeur/Membre du Conseil | - |
Westhaven Therapeutics Corp. | Directeur/Membre du Conseil | - |
DAS Therapeutics, Inc.
 DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Directeur/Membre du Conseil | - |
Anciens postes connus de Kathleen Clarence-Smith
| Sociétés | Poste | Fin |
|---|---|---|
| GT BIOPHARMA, INC. | Directeur Général | - |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Fondateur | 01/01/2016 |
Stanford Group Co.
 Stanford Group Co. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/02/2009 |
| SANOFI | Corporate Officer/Principal | 01/01/1987 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ | - |
Formation de Kathleen Clarence-Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
GT Biopharma, Inc.
 GT Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovering, developing and commercializing novel therapeutics | Health Technology |
Stanford Group Co.
Stanford Group Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Université François-Rabelais de Tours
 Université François-Rabelais de Tours Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Km Pharmaceutical Consulting LLC
Km Pharmaceutical Consulting LLC Km Pharmaceutical Consulting LLC is a specialized consulting and project management firm serving the pharmaceutical industry. The private company is based in Washington, DC. The company provides strategic consulting and regulatory services throughout drug development, including clinical and non-clinical program management, FDA regulatory interactions, and patent and licensing strategies. It supports clients with early strategic planning, oversight, and customized team assembly, particularly assisting non-US companies and biotech firms lacking US-based resources. The company’s expertise includes clinical trial design and management, regulatory submissions, development plan formulation, safety and efficacy data interpretation, and due diligence. The company was founded by Kathleen E. Clarence-Smith. | |
Prestwick Scientific Capital, Inc. | |
Prestwick Chemical, Inc.
 Prestwick Chemical, Inc. Pharmaceuticals: OtherHealth Technology Founded in 1999, Prestwick Chemical, Inc. specializes in providing diverse, high-quality chemical libraries to support drug discovery and biomedical research worldwide. The private company is based in Washington, DC. The company's flagship Prestwick Chemical Library® comprises 1,760 mainly FDA-approved, off-patent small-molecule drugs designed to accelerate early drug discovery. The company offers multiple specialized libraries tailored to specific research needs, including a GPCR drug library, an OnCombo library for identifying synergistic anticancer drug combinations, a peptidic macrocycle library for medicinal chemistry applications, and a C. elegans library for chemical diversity and tolerability studies. All libraries emphasize chemical and pharmacological diversity, high purity, stability, and are accompanied by comprehensive databases detailing targets, therapeutic classes, side effects, ADMET properties, and other relevant data. Prestwick Chemical also provides compound supply, analog search, hit confirmation, SAR analysis, and custom synthesis services to support flexible R&D solutions. | Health Technology |
OXIS Biotech, Inc.
 OXIS Biotech, Inc. BiotechnologyHealth Technology Develops prodrug therapeutic for the treatment of cancer | Health Technology |
Georgetown Translational Pharmaceuticals, Inc.
 Georgetown Translational Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Provides treatment for neuropathic pain, refractory epilepsies, the symptoms of myasthenia gravis, and motion sickness | Health Services |
Chase Therapeutics Corp.
 Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in developing medications for treating neurodegenerative disorders | Health Technology |
Riverside Pharmaceuticals Corp.
Riverside Pharmaceuticals Corp. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Westhaven Therapeutics Corp. | |
DAS Therapeutics, Inc.
DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Health Technology |
